ArticleOPEN ACCESS

Venetoclax–proteasome inhibitor–dexamethasone for unfit patients with blastic plasmacytoid dendritic cell neoplasm

Blood Advances
DOI: 10.1182/bloodadvances.2024014590
5Citations
Citations of this article
4Readers
Mendeley users who have this article in their library.

This article is free to access.

Cite

CITATION STYLE

APA

Khalife-Hachem, S., Pages, A., Akoury, E., Bonnet, S., Birsen, R., Busquet, C., … Ghez, D. (2025, February 25). Venetoclax–proteasome inhibitor–dexamethasone for unfit patients with blastic plasmacytoid dendritic cell neoplasm. Blood Advances. American Society of Hematology. https://doi.org/10.1182/bloodadvances.2024014590

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free